Salesforce (CRM) Stock Forecast & Price Target

$355.85 +1.00 (+0.28%)

(As of 09:34 AM ET)

Salesforce - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 41 Analyst Ratings

Sell
0

Hold
9

Buy
32

Based on 41 Wall Street analysts who have issued ratings for Salesforce in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 41 analysts, 9 have given a hold rating, 28 have given a buy rating, and 4 have given a strong buy rating for CRM.

Consensus Price Target

$375.50
5.52% Upside

According to the 41 analysts' twelve-month price targets for Salesforce, the average price target is $375.50. The highest price target for CRM is $450.00, while the lowest price target for CRM is $236.00. The average price target represents a forecasted upside of 5.52% from the current price of $355.85.

Get the Latest News and Ratings for CRM and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Salesforce and its competitors.

CRM Analyst Ratings Over Time

Type	Current Forecast 12/13/23 to 12/12/24	1 Month Ago 11/13/23 to 11/12/24	3 Months Ago 9/14/23 to 9/13/24	1 Year Ago 12/13/22 to 12/13/23
Strong Buy	4 Strong Buy rating(s)	4 Strong Buy rating(s)	3 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	28 Buy rating(s)	25 Buy rating(s)	26 Buy rating(s)	25 Buy rating(s)
Hold	9 Hold rating(s)	9 Hold rating(s)	9 Hold rating(s)	12 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$375.50	$316.37	$304.41	$256.31
Forecasted Upside	5.52% Upside	-7.28% Downside	19.58% Upside	-0.41% Downside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

WARNING: Don’t let the national media distract you (Ad)

Millions of traders could get blindsided by this election-year shock on December 18th… And if you do nothing now, you could wind up panicking in the next 30 days… or worse, making a costly mistake.

Click here to watch his emergency briefing >>>

CRM Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CRM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Salesforce Stock vs. The Competition

Type	Salesforce	Computer and Technology Companies	S&P 500
Consensus Rating Score	2.90	2.68	2.51
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	5.08% Upside	74.19% Upside	9.52% Upside
News Sentiment Rating	Positive News See Recent CRM News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/12/2024	Macquarie 1 of 5 stars		Initiated Coverage	Neutral	$370.00	+4.27%
12/4/2024	Loop Capital 2 of 5 stars		Boost Target	Hold ➝ Hold	$340.00 ➝ $360.00	-2.16%
12/4/2024	JPMorgan Chase & Co. 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$340.00 ➝ $380.00	+3.28%
12/4/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$400.00 ➝ $425.00	+15.51%
12/4/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$300.00 ➝ $420.00	+16.53%
12/4/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$368.00 ➝ $390.00	+7.93%
Get the Latest News and Ratings for CRM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Salesforce and its competitors with MarketBeat's FREE daily newsletter.
12/4/2024	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Verkhovski Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Sector Outperform ➝ Sector Outperform	$425.00 ➝ $440.00	+22.47%
12/4/2024	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$315.00 ➝ $415.00	+14.17%
12/4/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$360.00 ➝ $400.00	+8.54%
12/4/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$385.00 ➝ $415.00	+25.09%
12/4/2024	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Neutral ➝ Neutral
12/4/2024	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$385.00 ➝ $425.00	+28.10%
12/4/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$380.00 ➝ $400.00	+20.57%
12/4/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$390.00 ➝ $425.00	+28.10%
12/4/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$415.00 ➝ $425.00	+28.10%
12/4/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$345.00 ➝ $375.00	+13.03%
12/4/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$340.00 ➝ $430.00	+29.61%
12/4/2024	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$400.00 ➝ $440.00	+32.62%
12/4/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$390.00 ➝ $440.00	+32.62%
12/4/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$330.00 ➝ $405.00	+22.07%
12/3/2024	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$250.00 ➝ $300.00	-9.32%
12/3/2024	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Market Outperform ➝ Market Outperform	$450.00 ➝ $450.00	+36.03%
12/2/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Bracelin Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$325.00 ➝ $395.00	+19.70%
11/25/2024	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$325.00 ➝ $375.00	+9.64%
11/22/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$275.00 ➝ $360.00	+5.26%
11/21/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$290.00 ➝ $340.00	+0.01%
11/19/2024	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy
11/12/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$275.00 ➝ $330.00	-4.35%
10/17/2024	Cfra Subscribe to MarketBeat All Access for the recommendation accuracy rating	Aaron Siegel Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target		$343.00	+16.88%
10/2/2024	Northland Capmk Subscribe to MarketBeat All Access for the recommendation accuracy rating	N. Chokshi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/30/2024	Phillip Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Accumulate	$305.00	+20.72%
8/29/2024	FBN Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Seyrafi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/29/2024	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Slowinski Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/29/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$234.00 ➝ $236.00	-8.87%
8/29/2024	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$335.00 ➝ $335.00	+28.58%
8/29/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Strong-Buy ➝ Strong-Buy	$325.00 ➝ $350.00	+35.19%
8/26/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$300.00 ➝ $300.00	+13.39%
5/30/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$350.00 ➝ $300.00	+39.82%
5/30/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$345.00 ➝ $300.00	+10.25%
4/16/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$365.00	+33.82%
WARNING: Don’t let the national media distract you (Ad) Millions of traders could get blindsided by this election-year shock on December 18th… And if you do nothing now, you could wind up panicking in the next 30 days… or worse, making a costly mistake. Click here to watch his emergency briefing >>>
3/21/2024	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Sector Weight
3/6/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$290.00 ➝ $354.00	+16.46%
9/15/2023	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$267.00	+22.04%
6/1/2023	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Baldry Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy
6/1/2023	Societe Generale Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold
3/2/2023	Atlantic Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$140.00 ➝ $200.00	+19.51%
2/21/2023	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform	$160.00 ➝ $170.00	+2.92%
1/20/2023	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 09:51 AM ET.

Should I Buy Salesforce Stock? CRM Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, December 5, 2024. Please send any questions or comments about these Salesforce pros and cons to contact@marketbeat.com.

Salesforce
Bull Case

Here are some ways that investors could benefit from investing in Salesforce, Inc.:

Salesforce, Inc. has a strong average price target of $343.89, indicating potential for growth from the current stock price of $330.82.
The company has received a consensus rating of "Moderate Buy" from analysts, with a significant number of buy ratings suggesting positive market sentiment.
Salesforce, Inc. recently announced a quarterly dividend of $0.40 per share, which translates to an annualized dividend yield of 0.48%, providing income to shareholders.
Insider transactions indicate confidence in the company, with recent sales totaling 144,510 shares, suggesting that insiders are managing their holdings while still retaining a significant ownership stake of 3.20%.
The stock has shown resilience with a 52-week high of $348.86, reflecting strong performance and investor interest in the company's growth prospects.

Salesforce
Bear Case

Investors should be bearish about investing in Salesforce, Inc. for these reasons:

The company's price-to-earnings (P/E) ratio stands at 57.53, which is relatively high, indicating that the stock may be overvalued compared to its earnings.
Salesforce, Inc. has a PEG ratio of 2.99, suggesting that the stock's price is high relative to its expected earnings growth, which could deter value-focused investors.
Recent insider sales, while not necessarily negative, could signal a lack of confidence in the stock's short-term performance, as insiders sold shares valued at over $42 million in the last three months.
The company's debt-to-equity ratio of 0.15 indicates low leverage, but it also suggests limited financial flexibility in times of economic downturns.
With a current ratio of 1.04 and a quick ratio of 1.04, the company is just above the threshold for short-term liquidity, which may raise concerns about its ability to cover short-term obligations.

CRM Forecast - Frequently Asked Questions

: According to the research reports of 41 Wall Street equities research analysts, the average twelve-month stock price forecast for Salesforce is $375.50, with a high forecast of $450.00 and a low forecast of $236.00.
: 41 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Salesforce in the last year. There are currently 9 hold ratings, 28 buy ratings and 4 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CRM shares.
: According to analysts, Salesforce's stock has a predicted upside of 5.52% based on their 12-month stock forecasts.
: Over the previous 90 days, Salesforce's stock had 4 upgrades and 1 downgrade by analysts.
: Salesforce has been rated by research analysts at Bank of America, Barclays, BMO Capital Markets, Canaccord Genuity Group, Cfra, Citigroup, DA Davidson, Erste Group Bank, Guggenheim, Jefferies Financial Group, JMP Securities, JPMorgan Chase & Co., Loop Capital, Macquarie, Morgan Stanley, Needham & Company LLC, Northland Capmk, Northland Securities, Oppenheimer, Piper Sandler, Robert W. Baird, Royal Bank of Canada, Scotiabank, Stifel Nicolaus, TD Cowen, The Goldman Sachs Group, Truist Financial, UBS Group, Wedbush, and Wells Fargo & Company in the past 90 days.
: Analysts like Salesforce more than other "computer and technology" companies. The consensus rating score for Salesforce is 2.88 while the average consensus rating score for "computer and technology" companies is 2.68. Learn more on how CRM compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

WARNING: Don’t let the national media distract you (Ad)

Click here to watch his emergency briefing >>>

This page (NYSE:CRM) was last updated on 12/12/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Salesforce (CRM) Stock Forecast & Price Target